Two Isoforms of the Guanine Nucleotide Exchange Factor, Daple/CCDC88C Cooperate as Tumor Suppressors

Ear, Jason; Dunkel, Ying; Mittal, Yash; Lim, Blaze B. C.; Liu, Lawrence; Holda, Magda K.; Nitsche, Ulrich; Barbazán, Jorge; Goel, Ajay; Janssen, Klaus-Peter; Aznar, Nicolas; Ghosh, Pradipta

doi:10.1038/s41598-019-48420-w

Download PDF

Article
Open access
Published: 20 August 2019

Two Isoforms of the Guanine Nucleotide Exchange Factor, Daple/CCDC88C Cooperate as Tumor Suppressors

Jason Ear ORCID: orcid.org/0000-0002-8580-7748^1,2^na1,
Ying Dunkel¹^na1,
Yash Mittal¹,
Blaze B. C. Lim ORCID: orcid.org/0000-0002-7980-8584¹,
Lawrence Liu¹,
Magda K. Holda¹,
Ulrich Nitsche³,
Jorge Barbazán⁴,
Ajay Goel ORCID: orcid.org/0000-0003-1396-6341⁵,
Klaus-Peter Janssen³,
Nicolas Aznar^1,6^na1 &
…
Pradipta Ghosh^1,2,7

Scientific Reports volume 9, Article number: 12124 (2019) Cite this article

1467 Accesses
5 Citations
9 Altmetric
Metrics details

Subjects

Abstract

Previously, Aznar et al., showed that Daple/CCDC88C enables Wnt receptors to transactivate trimeric G-proteins during non-canonical Wnt signaling via a novel G-protein binding and activating (GBA) motif. By doing so, Daple serves two opposing roles; earlier during oncogenesis it suppresses neoplastic transformation and tumor growth, but later it triggers epithelial-to-mesenchymal-transition (EMT). We have identified and characterized two isoforms of the human Daple gene. While both isoforms cooperatively suppress tumor growth via their GBA motif, only the full-length transcript triggers EMT and invasion. Both isoforms are suppressed during colon cancer progression, and their reduced expression carries additive prognostic significance. These findings provide insights into the opposing roles of Daple during cancer progression and define the G-protein regulatory GBA motif as one of the minimal modules essential for Daple’s role as a tumor suppressor.

Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF

Article 27 March 2024

Sandi Radko-Juettner, Hong Yue, … Charles W. M. Roberts

Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities

Article Open access 03 January 2022

Jiaqi Liu, Qing Xiao, … Gang Yin

The JAK/STAT signaling pathway: from bench to clinic

Article Open access 26 November 2021

Xiaoyi Hu, Jing li, … Wei Wang

Introduction

We previously defined a novel paradigm in Wnt signaling in which Wnt receptors, Frizzled (FZDs), activate G-proteins and trigger non-canonical Wnt signaling via Daple/CCDC88C¹. Daple, a multimodular signal transducer and a cytosolic protein, was originally discovered as a Dishevelled (Dvl)-binding protein that regulates Wnt signaling^2,3. Subsequent work showed that Daple directly binds ligand-activated FZDs, and serves as a guanine-nucleotide exchange factor (GEF) that activates the G-protein, Gαi¹. Binding to the G-protein is mediated via Daple’s C-terminally located Gα-binding and activating (GBA) motif; such binding triggers non-canonical activation of Gαi¹. Binding to FZD is also brought on via a C-terminally located stretch distal to the GBA motif. Upon ligand stimulation, Daple dissociates from Dvl, binds to and displaces Dvl from FZDs, and assembles a Daple:Gαi complexes on the receptor. How Daple:Dvl complexes are disassembled was unknown until recently, when we demonstrated that phosphorylation of Daple’s PDZ-binding motif (PBM) by both receptor and non-receptor tyrosine kinases can trigger this change⁴. Disassembly of Daple:Dvl complexes and formation of FZD:Daple:Gαi complexes facilitates the activation of Gαi near ligand-activated Wnt receptors. Daple activates Gαi within the FZD:Daple:Gαi complexes; such non-canonical activation of Gαi by Daple-GBA suppresses cAMP, whereas released ‘free’ Gβγ heterodimers enhance Rac1 and PI3K-Akt signals¹. Although Daple-dependent enhancement of non-canonical Wnt signals can suppress tumor growth¹, it can also fuel EMT, trigger cancer cell migration and invasion^1,5 and drive metastasis⁶. Furthermore, elevated expression of Daple-GBA in circulating tumor cells prognosticates a poor outcome⁷. In doing so, Daple serves a dual role during oncogenic progression—a tumor suppressor early during oncogenesis and driver for metastatic invasion later.

Here we identified a novel Daple isoform (Daple-V2) which corresponds only to the C-terminal region of full length Daple (Daple-fl; RefSeq NM_001080414). We demonstrate that Daple-V2 possesses all the functional domains to bind Dvl, FZD7 and Gαi and represents the smallest autonomous Daple unit able to inhibit the β-catenin/TCF/LEF pathway and suppress tumor cell growth. We also demonstrate that both isoforms have different subcellular distribution, and unlike Daple-fl, Daple-V2 does not enhance tumor cell invasiveness and may, therefore, serve as a more effective tumor suppressor and a better prognostic marker than Daple-fl.

Results and Discussion

Identification of various isoforms of Daple in cells

We noted that there are 6 other transcript variants catalogued in Ensembl and/or UniProt databases: V2 (552aa), V3 (506aa), V4 (478aa), V5 (96aa), V6 (88aa) and V7 (234aa) (Supplementary Fig. 1A). Among them, V2, V3 and V4 are predicted to encode stretches within Daple’s C-terminus, whereas V5, V6 and V7 are predicted to encode stretches within Daple’s N-terminus. Because distinct protein isoforms generated from single genes are known to contribute to the diversity of the proteome⁸, we asked if Daple’s seemingly opposite and bi-faceted roles in cancers may be due, in part, to the functions of varying isoforms of the same protein. Because prior work by others and us have demonstrated the importance of the PBM and GBA modules within the C-terminus of Daple in the regulation of Wnt signaling, we narrowed our analysis to transcripts encoding Daple’s C-terminus.

We noted that Daple-V2 and V3 differs from Daple-fl by a unique 5′ end (Fig. 1A) which adds a sequence comprised of 5 amino acids (MSVLS) on the N-terminus of the isoforms. Upon inspection of the V2 and V3 variant, we noticed that both transcripts contained the same transcript ID but are different version of the same transcript (Supplementary Fig. 1A). This arose from annotation of various assemblies in the Ensembl database (V2 from assembly GRCh37 and V3 from GRCh38). In order to confirm if one or both transcripts exist in the cell, we utilized a common primer set to amplify both the V2 and V3 gene from cDNA. Surprisingly only one amplicon was seen from the PCR analysis (Fig. 1B). This product was isolated and cloned into an expression vector and transfected into cells for further analysis.

The V3 transcript is unique from the other C-terminus transcript in that it is missing a stretch of amino acid in exon 30 (using Daple-fl nomenclature, Fig. 1A). To further confirm if, between V2 and V3, V2 is the sole species, PCR analysis on a region flanking the missing sequence was performed (Fig. 1B). No product corresponding to V3 was observed, indicating that Daple-V2 is the major, and perhaps the only transcript between V2 and V3.

Analysis of the 5′-untranslated region (UTR) between Daple-fl, V2, and V4 revealed that the full-length transcript contains a putative consensus kozak sequence (high strength of prediction), with two notable features – a G on the +4 and an A on the −3^9,10. The putative kozak sequence on V2 only has one of these features (an A on the −3 end), while V4 has neither property on its 5′UTR (Fig. 1A). In summary, when ranked by kozak strength Daple-fl was predicted to be highest, followed by Daple-V2 and then Daple-V4. This finding suggests that V2 might have a higher translation efficiency and thus may translate into a protein that is highly abundant. When we assessed the expression of these C-terminal isoforms, we found that both V2 and V4 transcripts were detected in cultured cells and colon tissues (Supplementary Fig. 2).

Daple-V2 is the most abundant isoform that is expressed in both normal and tumor tissues

To determine how the expression of Daple isoforms change during normal to cancer progression, we analyzed the relative transcript expression of each Daple isoform in normal and tumor tissues annotated in the TCGA (The Cancer Genome Atlas) data portal using the web server- ISOexpresso. This server facilitates expression-based isoform-level analysis. Such analysis revealed that the cumulative levels of Daple transcripts are reduced from a median of 23.14 to 15.6 between normal colon and colorectal tumor tissues, respectively (Fig. 1C), however, Daple-V2 remained the most abundant isoform (besides Daple-fl) in both cases (Fig. 1D–F).

When we expanded this analysis to include all 9,690 tumors and 732 normal controls of 30 cancer types annotated in the TCGA data portal, Daple-V2 still remained the most dominant isoform across all tissue types (Supplementary Fig. 3A,B). These findings indicate that Daple-V2 is the most abundant isoform of Daple (in normal and tumor tissues) that is translated into protein and has the minimal motifs/modules necessary to scaffold Dvl, FZD7 and G-proteins.

Validation of Daple-V2, a major isoform of Daple in cells

We first began by asking if the isolated Daple-V2 gene product that we cloned, actually expressed as a protein. We found that is indeed the case; a product of predicted molecular weight was detected by immunoblotting in cells exogenously expressing the Daple-V2 construct using an antibody that was raised against Daple’s C-terminus (Fig. 2A). Next we asked if Daple-V2 is expressed in cells (endogenous pool). Because all transcripts sharing the C-terminal GBA and PDZ-binding motifs share an identical 3′UTR (Fig. 1A), we utilized a previously-validated 3′UTR-targeted shRNA approach to knockdown various isoforms of Daple in cells¹. Full length immunoblots revealed that Daple-fl (~250 kDa) and several bands around the corresponding molecular weight of Daple-V2 (~70 kDa) are depleted in shDaple cells compared to shControl (Fig. 2B). Because most of the bands observed ~70 kDa were depleted in shDaple cells, these may represent Daple-V2, its various posttranslational modified forms, and/or other transcript variants. Successful targeting of Daple-fl and Daple-V2 was further confirmed through measurements of mRNA transcripts by quantitative RT-PCR (qPCR). Compared to shControl cells, shDaple cells had a significant decrease in both full length and V2 isoforms (Fig. 2C,D).

Next, we checked the expression of mRNA and protein of Daple-fl and Daple-V2 in normal adult colon. We analyzed mRNA levels of both Daple-fl and Daple-V2 in 14 colons samples by qPCR; both isoforms were detected (Fig. 2E). Furthermore, we confirmed the protein expression of Daple-fl and Daple-V2 (Fig. 2F) by analyzing lysates of mucosal biopsies taken from normal colons by immunoblotting using an anti-Daple-CT antibody raised against aa 1660–2028 ([previously validated in¹ and expected to detect both Daple-fl and -V2 isoforms).

Daple-V2 represents the smallest autonomous Daple unit that can bind Dvl, FZD7 and Gαi

We noted that the V2 isoform possesses the C-terminal region of the full length Daple protein and hence, contains a GBA, a frizzled binding domain, and a PDZ Binding motif (PBM) (Fig. 3A). To study the properties of Daple-V2 and compare them with the previously described full-length protein, we cloned the Daple-V2 transcript into a plasmid for mammalian expression as a N-terminally myc-tagged protein, just as we did previously for Daple-fl¹. We also generated V2 constructs with previously defined specific mutants of Daple that lack the important motifs, GBA [Daple-V2-FA (F194A)] and PBM [Daple-V2- ΔPBM (deleted from 549–552aa)] and used these mutants to further decipher the properties of Daple-V2. As expected, we confirmed by GST pulldown assays that myc-Daple-V2 interacts with Gαi3, PDZ domain of Dvl and the cytoplasmic tail of FZD7 (Fig. 3B–D).These findings indicate that Daple-V2 represents the smallest autonomous Daple unit possessing the key biochemical features of the C-terminus of Daple-fl previously described¹.

Daple-V2 and Daple-fl have distinct subcellular localizations

Prior work from our group demonstrated the importance of the N-terminal coiled-coil domain (which is absent in Daple-V2) in localizing Daple to the pericentriolar recycling compartment¹¹. Therefore, we next asked if the two isoforms of Daple differs in its subcellular localization. As expected, transfection of mCherry tagged Daple-fl into HeLa cells revealed that the full-length protein localizes to a pericentriolar compartment, as determined by their proximity to the centrosomal marker γ-tubulin (Fig. 3G). By contrast, Daple-V2 is distributed ubiquitously throughout the cell and was seen even within the nucleus (Fig. 3E–G). Immunoblotting using mCherry or Daple antibodies confirmed that the exogenously expressed Daple protein is stable and the observed localization is not due to degradation of the protein (Supplementary Fig. 4). Others have noted that localization of Daple can differ depending on the chemical fixative used¹². We observed the contrasting localizations of Daple-fl and Daple-V2 regardless of whether cells were live or fixed with different fixatives, i.e., paraformaldehyde or methanol (Fig. 3E–G). These results indicate that the observed difference in the localization of Daple’s isoforms is likely to be real. Because the subcellular localization of a signal transducer is a key determinant of the signals it modulates, our findings also suggest that differential localization of Daple-fl and Daple-V2 may translate to different functional roles in the cell, and some of those functions may be dictated by their compartmentalized actions.

Daple-V2 antagonizes Wnt signaling via the β-Catenin/TCF/LEF pathway, suppresses growth and proliferation but does not trigger EMT or cell invasion

We previously demonstrated that Daple-fl and more specifically its GBA motif, antagonizes the β-catenin-dependent Wnt signaling pathway and inhibits colony growth, but enhances the PI3K-Akt and Rac1 signals, EMT and invasion¹. Because Daple-V2 possesses a GBA motif, and because the motif is required for binding G-proteins, we asked if this motif is functional in cells. Using DLD1 colon cancer cells stably expressing 7-TGP (Fig. 4A), an eGFP expressing Wnt activity reporter construct¹, or parental DLD1 cells (Fig. 4B), we generated stable cell lines expressing Daple-V2 wild-type (WT) and GEF-deficient (F194A; FA) mutant. For comparison, we used previously developed and characterized¹ DLD1 lines expressing the Daple-fl-WT.

We found that Daple-V2 and Daple-fl have two similarities and one dissimilarity. First similarity was that both Daple-fl and Daple-V2 antagonize the β-catenin/TCF/LEF pathway (Fig. 4C); Daple-V2-WT, but not Daple-V2-FA, inhibited eGFP expression (Fig. 4A,D), indicating that the inhibitory effect of Daple-V2 on the canonical Wnt pathway required an intact GBA motif. Consistently, both Daple-fl and Daple-V2 reduced the transcription of downstream target genes Axin-2 and SFRP-1; once again, the presence of an intact GBA motif was critical for such inhibition (Fig. 4E,F). Second similarity was that expression of either Daple-fl or Daple-V2 inhibited anchorage-dependent colony growth of DLD1 cells by ~50% and 90%, respectively (Fig. 4G,H). Such growth suppressive effect required an intact GBA motif because, compared to Daple-V2-WT, expression of the GBA-deficient F194A [¹ corresponding to F1675 in Daple-fl; henceforth, FA] mutant not only failed to inhibit cell colony formation, but also enhanced anchorage-dependent growth (Fig. 4I,J).

The dissimilarity between Daple-fl and Daple-V2 was observed in whether they used their GBA motifs to trigger EMT. Compared to cells expressing the GBA-deficient FA mutants of Daple-V2 or Daple-fl, those expressing Daple-fl WT had significantly higher expression of Lox-L3 and Vimentin, two genes commonly associated with epithelial-mesenchymal transition (EMT) (Supplementary Fig. 5). Furthermore, in 3-D matrigel invasion assays using the transformed NIH3T3 cells, as done previously¹, enhanced invasion, as determined by the area of invasion was detected exclusively in the presence of Daple-fl-WT, but not in cells expressing Daple-V2 or Daple-fl-FA, indicating that only Daple-fl can trigger cell invasion (Fig. 4K,L). We found that expression of Daple-fl, but not Daple-V2 is increased in the invading margins of tumors compared to the non-invasive tumor cores (Fig. 4M,N), which is in keeping with our findings that Daple-V2 does not contribute to EMT or higher invasiveness.

The ratio of Daple-fl and V2 isoforms shift when cells are exposed to Aspirin

Because both Daple isoforms can suppress the β-catenin/TCF/LEF pathway and anchorage-dependent colony growth, but only Daple-fl can induce EMT and invasiveness, we rationalized that tumor cells may regulate their expression differentially to their own advantage. To test if such is the case, we asked if levels of expression of Daple-fl and Daple-V2 change in response to Aspirin, a potent chemopreventive agent that reduces the risk of colorectal cancers (CRCs) by half^13,14. We found that the treatment of DLD1 cells with low-dose Aspirin reduces both mRNA and protein for Daple-fl (Fig. 4O,P), which has both tumor-suppressive and pro-metastatic properties. By contrast, Aspirin increased the mRNA and protein for Daple-V2 (Fig. 4O,P), which has only tumor-suppressive properties. Overall, the ratio of Daple-V2 to Daple-fl was increased. When we analyzed a panel of CRC cell lines representing diverse subtypes of CRCs and harboring different mutant driver oncogenes (Supplementary Fig. 6A), we found that the Aspirin-induced changes we observed in DLD1 cells was also observed in some other CRC cell lines, but not in all of them (Fig. 4Q). The ratio of Daple-V2:fl was increased exclusively in those cell lines which were previously shown to be most sensitive to the growth suppressive action of Aspirin¹⁵, and share a common driver oncogene, PIK3CA (Fig. 4Q, Supplementary Fig. 6). Whether these observed changes in Daple isoforms are due to Aspirin’s ability to inhibit cyclo-oxygenase-II (COX2), i.e., COX2-dependent or independent mechanisms^13,16 remain unknown. Regardless, what is clear is that these changes are consistent with Aspirin’s ability to suppress polyp-to-cancer progression in the colon^17,18, as well as its ability to inhibit metastatic progression of advanced CRCs^19,20,21.

Taken together, these findings demonstrate that compared to Daple-fl, Daple-V2 may serve as a more effective inhibitor of the β-Catenin-dependent canonical Wnt pathway and tumor growth in colonies, but it does not enhance EMT or invasion (Fig. 4R), and that their expression may be differentially regulated by tumor cells to gain advantages in growth and invasiveness. Findings also reveal that Aspirin-mediated growth suppression is associated with an increase in the Daple-V2:Daple-fl ratio, and that such a change occurs exclusively in CRC cells harboring a constitutively activated PI3K-Akt pathway.

The anti-proliferative roles of Daple-fl and Daple-V2 are additive; simultaneous suppression of both transcripts in colon cancers carries poor prognosis

Because both Daple-fl and Daple-V2 suppress colony growth, we asked if such effects are additive. To investigate this, we carried out growth curve assessment and cell viability assays on HeLa cell lines that have been depleted of endogenous Daple by shRNA and stably expressing myc-Daple-fl or myc-Daple-V2 either alone, or together [Fig. 5A; Daple-depleted HeLa lines have been extensively characterized using a variety of approaches¹]. In both assays we found that co-expression of Daple-fl and Daple-V2 isoforms suppressed cell growth and proliferation more effectively than compared to either isoform alone (Fig. 5B,C).

We previously showed that Daple-fl is downregulated earlier during cancer initiation (at the stage of polyp to cancer conversion), and that its expression at high levels carries a good prognosis in CRCs¹.We also showed that levels of Daple-fl is increased later during metastatic progression and in circulating tumor cells (CTCs), and that high levels of expression carry a worse prognosis. We asked if and how the expression of Daple-V2 changes during cancer progression in the colon and what, if any, may the prognostic impact of such changes. Once again, we found several similarities and one dissimilarity. Analysis by qPCR in 12 paired colorectal tumors and their adjacent normal tissue showed that, much like Daple-fl, the expression of Daple-V2 is decreased in CRCs (Fig. 5D). When we analyzed a cohort of patients with Duke’s Stage II CRCs, we found that tumors that express low Daple-V2 had a significantly higher incidence of oncogenic K-ras mutation (Fig. 5E; Table 1); no such correlation was seen in the case of Daple-fl. Tumors that express low Daple-fl (Fig. 5F) or low Daple-V2 (Fig. 5G) or low levels of both isoforms (Fig. 5H) have a higher frequency of progression to distant metastases. Kaplan-Meier analyses revealed that Daple-V2 is a better prognosticator than Daple-fl (compare Fig. 5I–L) when used standalone to stratify risk for recurrence-free survival (RFS) and disease-specific survival (DSS). When accounting for high vs low levels of both Daple isoforms, an additive prognostic impact was seen compared to each alone (Fig. 5M,N). A correlation analysis showed that Daple-V2, but not Daple-fl negatively correlates with the marker for proliferative index of tumor cells Ki67^22,23, and positive correlation with the tumor suppressor SAM and SH3-Domain Containing 1 (SASH1)^24,25 (Table 2). Together with our findings on cell lines (growth curve, Wnt reporter and tumor cell colony formation assays), these analyses on patient tumors suggest that while both isoforms suppress tumor cell proliferation, Daple-V2 may be a more potent suppressor of tumor cell growth and proliferation than Daple-fl. These findings also define the profile of dysregulated Daple-fl and Daple-V2 expression during oncogenic progression in the colon: both isoforms are suppressed during colorectal cancer progression, and low expression levels of both isoforms alone or simultaneously exhibit decreased survival.

Table 1 Source data for contingency analysis (Fisher’s exact test) comparing Daple-fl or Daple-V2 expression and the presence of wild-type (WT) or oncogenic K-Ras mutation in 173 stage II colorectal carcinomas in Fig. 5E.

Full size table

Table 2 Pearson’s correlation comparing Daple-fl or Daple-V2 expression and several tumor markers or histopathological parameters in 173 stage II colorectal carcinomas.

Full size table

Finally, we previously discovered that high levels of expression of Daple in CTCs of patients with metastatic (Duke’s Stage IV) CRCs is associated with poorer prognosis compared to those with low Daple in CTCs⁷; high Daple is associated with higher tumor recurrence at distant sites and poorer survival. Here we asked how each isoform contributed to the prognostic impact using the same cohort. We found that Daple-fl,but not Daple-V2, expression is increased in disseminated tumor cells compare to healthy subjects (Supplemental Fig. 7A,B). When we assessed their prognostic impact on survival, we found that although high expression of each isoform correlated with worse PFS (Supplementary Fig. 7C,F), only Daple-fl levels carried a prognostic impact for DSS and overall survival (OS) (Supplementary Fig. 7D,E,G,H). These findings are in keeping with our prior observations that pro-invasive and pro-EMT signatures are triggered exclusively by Daple-fl, but not Daple-V2 (Fig. 2Q).

From these results we deduce that both Daple-fl and Daple-V2 cooperatively suppress tumor cell proliferation, that both transcripts are reduced during adenoma-to-carcinoma progression, and that the two isoforms have an additive prognostic impact, in that their reduced expression in tumors carries a poor prognosis. However, the two isoforms differ in their ability to trigger EMT and invasion; Daple-fl, but not Daple-V2 can support that.

Daple is downregulated during adenoma-to-carcinoma conversion

Next we asked if suppression of Daple-fl and Daple-V2 transcripts during adenoma-to-cancer progression is also associated with reduced Daple proteins. Using an antibody raised against the C-terminus of Daple, which is identical between Daple-fl and Daple-V2, we confirmed that total Daple is expressed in the normal colon and in early and intermediate adenomas, but it is suppressed in advanced adenomas with villous features or high-grade dysplasia (Fig. 6A,B). In cancers, ~60% expressed Daple, but ~40% did not.

Taken together, our findings support the following model (Fig. 6C). While both Daple-fl and Daple-V2 isoforms serve as growth suppressors early during oncogenesis, only Daple-fl serves as a pro-metastatic protein later during cancer progression. While both are suppressed during the step of polyp-to-cancer conversion, only Daple-fl is induced later during cancer invasion and dissemination.

Conclusions

The major discovery we report here is the identification and characterization of a novel physiologic isoform of Daple, Daple-V2, which appears to contain the minimal modules that enable Daple to antagonize canonical β-Catenin-dependent Wnt signals and inhibit tumor cell growth and proliferation. Both isoforms are reduced during polyp-to-cancer progression in the colon. Compared to Daple-fl, Daple-V2 appears to be a more potent tumor suppressor and a better prognostic marker in primary tumors.

What Daple-V2 lacks is the ability to trigger EMT and invasion, which is a feature unique to Daple-fl. Consistent with these findings, we also found that although both isoforms collaboratively suppress tumor cell growth, and have an additive prognostic impact, only Daple-fl is increased in invasive margins and in CTCs disseminated during metastatic progression. Because we previously showed that a functional GBA motif is essential for Daple-fl to trigger EMT and invasion¹, that Daple-V2 cannot trigger EMT despite a functionally intact GBA suggests that these functions not only require the coupling of Daple’s C-terminus to G-proteins, but also the functions of its N-terminal HOOK and coiled-coil domains, e.g., phosphoinositide (PI3P) binding and localization to the pericentriolar recycling endosomes¹¹, or binding to the dynein-dynactin motor complex²⁶.

Although it remains unknown how cells modulate the expression of each Daple isoform, our studies provided precious clues. When exposed to the chemoprevention drug, Aspirin, CRC cells that are sensitive to its growth-suppressive action were able to suppress Daple-fl but concomitantly increased Daple-V2; this effect was observed only in CRC cell lines that harbor the PIK3CA mutation. Prior clinical trials in humans^27,28 and studies on cultured cells^15,29 have confirmed that CRCs/cells that harbor PIK3CA mutation are most sensitive to the growth-suppressive action of Aspirin. Based on the properties of each isoform, we conclude that such a tradeoff is expected to overall maximize the desirable tumor-suppressive effect of Daple without the undesirable pro-EMT and pro-invasive effects. In fact, a decrease in the levels of Daple-V2 with a concomitant increase in Daple-fl transcripts in the circulating blood has recently been shown to correlate with increased stemness markers, an aggressive disease course and a shorter relapse-free survival in patients with melanoma³⁰.

Despite the insights gained, a lot remains unknown. For example, it is possible that the mRNA for Daple-V2 isoform could have cellular functions independently of protein expression. Similarly, the numerous other splice variants, including those not interrogated here, may contribute to a rich complex of Daple biology in cancer.

In conclusion, we have revealed one of perhaps many ways how expression of Daple and its functions are regulated in the colon. Our findings that Daple isoforms can be pharmacologically manipulated to selectively augment its tumor-suppressive functions, while suppressing its pro-metastatic functions raises hope that therapeutic strategies could be tailored to meet such goals.

Materials and Methods

Reagents and antibodies

Unless otherwise indicated, all reagents were of analytical grade and obtained from Sigma-Aldrich. Cell culture media were purchased from Invitrogen. All restriction endonucleases and Escherichia coli strain DH5α were purchased from New England Biolabs. E. coli strain BL21 (DE3) and phalloidin-Texas Red were purchased from Invitrogen. Genejuice transfection reagent was from Novagen. PfuUltra DNA polymerase was purchased from Stratagene. Recombinant Goat anti-rabbit and goat anti-mouse Alexa Fluor 680 or IRDye 800 F(ab′)2 used for immunoblotting were from Li-Cor Biosciences. Mouse anti-α-tubulin and anti-actin were obtained from Sigma; anti-Myc was obtained from Covance, and anti-GFP from Santa Cruz Biotechnology. Rabbit anti–pan-Gβ (M-14), and anti-Gαi3 were obtained from Santa Cruz Biotechnology. Anti-Daple antibodies were generated in collaboration with Millipore using the C-terminus of Daple (1660–2028 aa) as an immunogen. WNT proteins were purified from 6 liters of CHO CM. CM was complemented with 1% Triton X-100 (vol/vol), 20 mM Tris-Cl pH 7.5, and 0.01% NaN₃.

Plasmid constructs and mutagenesis

Cloning of N-terminally tagged myc-Daple-fl and mCherry Daple-fl was carried out as described previously^1,11. The subsequent site-directed mutagenesis and truncated constructs (myc-Daple full length F1675A (FA) and deleted from 2025–2028 aa (ΔPBM) were carried out on this template using Quick Change as per manufacturer’s protocol. Cloning of N-terminally tagged myc-Daple-V2 was carried out by PCR cloning directly from HeLa cDNA using primers containing the unique 5′ region (MSVLS) in Daple V2 sequence (corresponding to UniProtKB - Q9P219-2) and being inserted into myc-pcDNA 3.1 (+) between Kpn-1/EcoR1. To clone mCherry Daple-V2, Daple-V2 was PCR amplified from HeLa cDNA with primers flanked with recombination site for Gateway cloning system (Invitrogen), as previously described¹¹. Daple-V2-FA (F194A) and Daple-V2- ΔPBM (deleted from 549–552aa) were also directly cloned out from pcDNA3.1(+)-Daple-fl-FA and pcDNA3.1(+)-daple-fl- ΔPBM. Cloning of rat Gα-proteins into pGEX-4T-1 GST-Gαi3 has been described previously^{31,32,33,34,35}. GST-tagged FZD7-CT construct³⁶ was a generous gift from Ryoji Yao (JFCR research institute, Japan). GST-Dvl2-PDZ was from Raymond Habas (Temple University, Philadelphia, PA).

Protein expression and purification

GST, GST-Gαi3, GST-PDZ and GST-FZD7 fusion constructs were expressed in E. coli strain BL21 (DE3) (Invitrogen) and purified as described previously^31,32,33. Briefly, bacterial cultures were induced overnight at 25 °C with 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). Pelleted bacteria from 1 L of culture were re-suspended in 10 ml GST-lysis buffer [25 mMTris-HCl, pH 7.5, 20 mMNaCl, 1 mM EDTA, 20% (v:v) glycerol, 1% (v:v) Triton TX-100, 2X protease inhibitor cocktail (Complete EDTA-free, Roche Diagnostics]. After sonication (4 × 20s, 1 min between cycles), lysates were centrifuged at 12,000 g at 4 °C for 20 min. Except for GST-FZD (see in vitro GST pulldown assay section), solubilized proteins were affinity purified on glutathione-Sepharose 4B beads (GE Healthcare). Proteins were eluted, dialyzed overnight against PBS and stored at −80 °C.

Cell culture and the rationale for choice of cells in various assays

Tissue culture was carried out essentially as described before^31,32,37. We used a total of 3 different cell lines in this work, each chosen carefully based on its level of endogenous Daple expression and the type of assay. All these cell lines were cultured according to ATCC guidelines. Cos7 cells were primarily used for transient overexpression of tagged Daple protein and lysates of these cells were used as source of proteins in pulldown assays. We chose to carry out these assays in Cos7 cells because they are easily and efficiently transfected (>90% efficiency) with most constructs. The added advantage is that they have no detectable endogenous Daple and provide a system to selectively analyze the properties of WT vs mutant Daple constructs without interference from endogenous Daple.

DLD1 were primarily used to study the effect of Daple on cancer cell growth properties (anchorage-dependent) and to assess the effect of Daple on the classical Wnt signaling pathway (βCatenin/TCF/LEF). There are several reasons why this cell line was chosen: (1) We focused on colorectal cancer in this study and DLD1 cells were appropriate to translate our findings because they are human colorectal cancer cells; (2) We determined that levels of Daple are significantly lower/undetectable (~10 fold) in these cells compared to normal colon (data not shown), thereby allowing us to reconstitute Daple expression exogenously and analyze the effect of various mutant Daple constructs without significant interference due to the endogenous protein; (3) These cells have been extensively characterized with respect to most oncogenes (ATCC database), and are highly tumorigenic in 2-D and 3-D cultures due to a mutation in KRAS (G13D) (Shirasawa et al., 1993; Ahmedet al., 2013); (4) They are a sensitive model to study how various manipulations of the noncanonical Wnt signaling pathway oppose the canonical Wnt pathway during tumor growth because they constitutively secrete Wnt ligands to maintain high levels of the canonical signaling³⁸ within the growth matrix. Production and secretion of endogenous ligands bypasses the need to add exogenous ligands repeatedly during prolonged assays that last ~2 weeks.

Low passage NIH3T3 fibroblasts were used exclusively in 3-D Matrigel invasion. The rationale for their use in invasion assay lies in the fact that non-transformed NIH3T3 fibroblasts are poorly invasive in vitro and non-tumorigenic and non-metastatic in animal studies^39,40,41,42. It is because of this reason, NIH3T3 cells are widely used to study proteins that can trigger a gain in invasive properties⁴³. The rationale for using NIH3T3 in the above assays is further strengthened by the fact that they are highly transfectable (~80% transfection efficiency with myc-Daple) and express Daple at very low endogenous levels (as determined by immunoblotting and qPCR) compared to normal colonic epithelium. Such expression pattern allows us to study the effect of various Daple mutant constructs without significant interference due to the endogenous protein. Multiple other CRC cell lines used in this work were obtained from ATCC and cultured as recommended.

Transfection; generation of stable cell lines and cell lysis

Transfection was carried out using Genejuice (Novagen) for DNA plasmids following the manufacturers’ protocols. DLD1 cell lines stably expressing Daple constructs were selected after transfection in the presence of 800 μg/ml G418 for 6 weeks. The resultant multiclonal pool was subsequently maintained in the presence of 500 μg/ ml G418. Daple expression was verified independently using anti-Daple antibody by immunoblotting and estimated to be ~5x the endogenous level.

Quantitative immunoblotting

For immunoblotting, protein samples were separated by SDS-PAGE and transferred to PVDF membranes (Millipore). Membranes were blocked with PBS supplemented with 5% non-fat milk (or with 5% BSA when probing for phosphorylated proteins) before incubation with primary antibodies. Infrared imaging with two-color detection and band densitometry quantifications were performed using a Li-Cor Odyssey imaging system exactly as done previously^{32,34,35,37,44}. Full length blots are provided in Fig. 2 and Supplementary Fig. 4 for endogenous and overexpressed exogenous Daple constructs. For all other instances, PVDF membrane was cut into strips for incubation with various antibodies (primary and secondary) to rigorously examine all antigens (phospho vs total target protein and loading controls) on the same gel/membrane to be reflective of balanced loading of samples. Cropped gels are indicated by borders. All Odyssey images were processed using Image J software (NIH) and assembled into figure panels using Photoshop and Illustrator software (Adobe).

Isoform expression analysis

These analyses were carried out using a web server, ISOexpresso⁴⁵, which facilitates expression-based isoform-level analysis of RNA sequencing data from 9,690 tumors and 732 normal controls of 30 cancer types from TCGA (The Cancer Genome Atlas) Data Portal. Transcripts are matched to gene and isoform information based on hg19/GRCh37 including IDs of genes and isoforms, genomic location, and known canonical/principal isoforms from UCSC Annotation database, UniProt (Universal Protein Resource), RefSeq (NCBI Reference Sequence Database),Ensembl, CCDS (Consensus CDS), APPRIS (Annotating principal splice isoforms), and HGNC (HUGO Gene Nomenclature Committee).We performed the analysis using the server’s ‘Isoform Expression View function’ which allows the analysis of tissue-specific RNA expression patterns of isoforms by selecting one or more tissues (cancer types) and querying a gene of interest.

In vitro GST pulldown

Purified GST alone, GST-Gαi3 or GST-PDZ (5 µg) were immobilized on glutathione-Sepharose beads and incubated with binding buffer [50 mM Tris-HCl (pH 7.4), 100 mM NaCl, 0.4% (v:v) Nonidet P-40, 10 mM MgCl₂, 5 mM EDTA, 30 µM GDP, 2 mM DTT, protease inhibitor mixture] for 90 min at room temperature as described before^31,32,37,46. Lysates (~250 µg) of Cos7 cells expressing appropriate myc-Daple-V2 constructs were added to each tube, and binding reactions were carried out for 4 h at 4 °C with constant tumbling in binding buffer [50 mM Tris-HCl (pH 7.4), 100 mM NaCl, 0.4% (v:v) Nonidet P-40, 10 mM MgCl₂, 5 mM EDTA, 30 µM GDP, 2 mM DTT]. Beads were washed (4x) with 1 mL of wash buffer [4.3 mM Na₂HPO₄, 1.4 mM KH₂PO₄ (pH 7.4), 137 mM NaCl, 2.7 mMKCl, 0.1% (v:v) Tween 20, 10 mM MgCl₂, 5 mM EDTA, 30 µM GDP, 2 mM DTT] and boiled in Laemmli’s sample buffer. Immunoblot quantification was performed by infrared imaging following the manufacturer’s protocols using an Odyssey imaging system (Li-Cor Biosciences).

GST-FZD7-CT construct was immobilized on glutathione-Sepharose beads directly from bacterial lysates by overnight incubation at 4 °C with constant tumbling as described before¹. Next morning, GST-FZD7-CT immobilized on glutathione beads were washed and subsequently incubated with His-tagged Daple-CT or Gαi3 proteins at 4 °C with constant tumbling. Washes and immunoblotting were performed as previously.

β-Catenin reporter assays

These assays were carried out using the well-established reporter 7xTcf-eGFP(7TGP)⁴⁷. Stable cells lines expressing this reporter were generated by lentiviral transduction and subsequent selection using standard procedures. Lentiviral infection and selection were performed according to standard procedures. Briefly, 10 cm plates DLD1 cells at 70% confluency were incubated with media containing 8 µg/mL polybrene and 10 µl of lentivirus for 6 h. After 24 hours post infection, selection of puromycin-resistant clones was initiated by adding the antibiotic at 2 µg/ml final concentration. The resultant DLD1-7TGP stable cells were subsequently transfected with various myc-Daple V2 constructs and selected for G418 resistance as described earlier in methods. The DLD1-7TGP cells stably expressing myc-Daple were incubated overnight at 0.2% FBS, analyzed by fluorescence microscopy, and photographed prior to lysis. Whole cell lysates samples were then boiled in Laemmli’s sample buffer and GFP protein expression was monitored by immunoblotting.

Cell proliferation assays

Two complementary methods were used. For cell counting assays, cells were seeded at 1 × 104 per well in Ham’s F12 media with 10% (v/v) FBS and grown at 37 °C in a humidified 5% CO₂ incubator. At various times cells were trypsin released and manually counted with a haemocytometer. Results are means ± SEM (n = 3). For cell viability assays, cells were seeded into 96-well plates at 2 × 10⁵ cells/ml and cultured in DMEM/Ham’s F12 media supplemented with 2% FBS for 1–5 days. Cell growth was documented every 24 hours via a colorimetric assay using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Sigma). Absorbance values were collected at 490 nm using a SpectraMax 190 microplate reader (Molecular Devices, Sunnyvale, CA, USA). Control samples were treated with vehicle (0.1% DMSO or ethanol in DMEM/Ham’s F12 culture media). In each individual experiment, proliferation was determined in triplicate, and the overall experiment was repeated at least three times.

Anchorage-dependent colony growth assay

Anchorage-dependent growth was monitored on solid (plastic) surface. Approximately ~1000 DLD1 cells stably expressing various Daple constructs were plated in 6-well plates and incubated in 5% CO₂ at 37 °C for ~2 weeks in 0.2% FBS growth media. Colonies were then stained with 0.005% crystal violet for 1 h. The remaining DLD1 cells were lysed and analyzed by WB to confirm Daple construct expression. Each experiment was analyzed in triplicate.

Invasion assays

NIH3T3 cell invasion assay in 3D culture was performed according to the manufacturer’s protocol (Trevigen, Cultrex 3D Spheroid BME Cell Invasion Assay, catalog #3500–096-K). Briefly, NIH3T3 cells (3000 cells) transfected with empty vector (control) or myc-Daple constructs were incubated first in the Spheroid Formation extracellular matrix (ECM) containing 0.2% FBS for 3 days. Invasion matrix was then added and layered on top with media containing FBS. Serum-triggered cell invasion was photographed under light microscope every day for 10 days and fresh media (FBS concentration is increased each time in order to maintain a gradient) was replenished every 48 hours. Photographs were analyzed and pseudocolored by Image J to reflect cell density.

Patient cohort for mRNA analysis

The ethics committee of the Klinikumrechts der Isar, Munich, Germany, approved collection of the patient samples (#1926/07, and #5428/12). All samples were obtained after prior informed written consent. Tumor tissue from 173 patients with histopathologically confirmed stage II (AJCC/UICC) colon cancer who underwent complete surgical resection (R0) between 1987 and 2006 was obtained, by a pathologist immediately after surgical resection. Specimens were transferred into liquid nitrogen and stored at −80 °C until further processing. None of the patients received neoadjuvant treatment. No metachronous tumors were found in the colon or rectum. As reported previously in detail, clinical data and post-operative follow-up was collected for all patients; moreover, DNA was isolated for KRAS and BRAF mutation analysis, as well as microsatellite instability testing⁴⁸. Total mRNA was extracted by standard procedures (Qiagen, Hilden, Germany), after histology guided sample selection to ensure a tumor cell content of >50%, and transcribed to cDNA as described in detail earlier, for expression analysis of DAPLE⁴⁸.These studies abide by the Declaration of Helsinki principles.

RNA isolation, standard curve and quantitative PCR (qPCR)

Total RNA was isolated using an RNeasy kit (QIAGEN) as per the manufacturers’ protocol. First-strand cDNA was synthesized using Superscript II reverse transcriptase (Invitrogen), followed by ribonuclease H treatment (Invitrogen) prior to performing quantitative real-time PCR. A standard curve, to quantify mRNA copy number, was constructed using larger PCR products (~700 bp) that included the target sequence used in qPCR. Reactions omitting reverse transcriptase were performed in each experiment as negative controls. Reactions were then run on a real-time PCR system (ABI StepOnePlus; Applied Biosystems). Gene expression was detected with SYBR green/Taqman assay (Invitrogen), and relative gene expression was determined by normalizing to GAPDH using the comparative ΔCt/Relative standard curve method.

Primer and probe sequences are as listed below.

Probes and primers used in verifying Daple isoforms (Fig. 1B)

Primer 1: ACCTGCCAAGAAAGAAGG

Primer 2: ACCTGCAGTGGCAATGGC

Probes and primers used in Taqman assays: for human tumor/tissue and CTC samples

GAPDH:

hGAPDH-fwd: 5′-CAGTTGTAGGCAAGCTGCGA-3′

hGAPDH-rev: 5′-TATGACAGGCCCGAAGCTTCT-3′

hGAPDH-probe: 5′-CCAAGCCTGAGGGCAAGGCTATAATAGATGAAT-3′

hGapdh-standard fwd: 5′-GCT GTG ACA TCA GGG CAA T-3′

hGapdh-standard rev: 5′-GGC GGT GGT GGC TTT ATT T-3′

Daple-fl:

hDaple-fl-fwd: 5′-CGGGACCTCACCAAGCAA-3′

hDaple-fl-rev: 5′-CTGCTGAGCTGCTGGCTCTT-3′

hDaple-fl-probe: 5′-CAACTCTGAGGGAGGACCTGGTGCTC-3′

hDaple-fl-Standard-fwd: 5′-GGATGCAGTCTTGGACGATAG-3′

hDaple-fl-Standard-rev: 5′-CTTCTTTCATGGCTAGTGTTGTTT-3′

Daple-V2:

hDaple-V2-fwd: 5′-GGAGCCTCAGGATATACGTGCA-3′

hDaple-V2-rev: 5′-TCAAGGCTGCCTCTGTGTGG-3′

hDaple-V2-probe: 5′-CAGGATGTCCGTACTAAGCCCTGGGGATC-3′

hDaple-V2 Standard-fwd: 5′-CACTCCCTGGACCATTTCTT-3′

hDaple-V2 Standard-rev: 5′-CTGTAGTGGTGGCTGAAGTT-3′

Primers used in SYBR-green assays: for cell-based analyses

Lox-3:

hq-LOXL3 fwd: 5′-ATGGGTGCTATCCACCTGAG-3′

hq-LOXL3 rev: 5′-GAGTCGGATCCTGGTCTCTG-3′

Axin-2:

hAxin-2-fwd: 5′-GAGTGGACTTGTGCCGACTTCA-3′

hAxin-2-rev: 5′-GGTGGCTGGTGCAAAGACATAG-3′

Vimentin:

hVim-fwd: 5′-AAGAGAACTTTGCCGTTGAA-3′

hVim-rev: 5′-GTGATGCTGAGAAGTTTCGT-3′

SFRP-1:

hSFRP-1-fwd: 5′-GAGTTTGCACTGAGGATGAAAA-3′

hSFRP-1-rev: 5′-GCTTCTTCTTCTTGGGGACA-3′

GADPH:

hGADPH q-fwd2: 5′-TCA GTT GTA GGC AAG CTG CGA CGT-3′

hGADPH q-rev2: 5′-AAGCCAGAGGCTGGTACCTAGAAC-3

DAPLE:

hDaple-fl-fwd: 5′-TGA CAT GGA GAC CCT GAA GGC TGA-3′

hDaple fl-rev2: 5′-TTTCATGCGGGCCTCACTGCTGA-3′

hDaple V2-Fwd: 5′-GTT GTC ACA CTC CCT GGA CCA TTT C-3′

hDaple V2-Rev: 5′-GCTTTGGTTTTAGATCCCCAGGGC-3′

Patient cohort for IHC analysis

Formalin-fixed paraffin embedded (FFPE) normal, polyp and cancer tissues used in this study were obtained from patients undergoing routine colonoscopies and provided by the section of Gastroenterology, VA San Diego Healthcare System. The protocol was approved by the Human Research Protection Program Institutional Review Board (IRB; protocol H130266). These studies abide by the Declaration of Helsinki principles.

Immunohistochemistry

Colon specimens of known histologic type were analyzed by IHC using a previously-validated anti-Daple-CT rabbit polyclonal antibody raised against Daple (1660–2028 aa) (1:50; Millipore Inc.). Briefly, formalin-fixed, paraffin-embedded tissue sections of 4 µm thickness were cut and placed on glass slides coated with 3-aminopropyl triethoxysilane, followed by deparaffinization and hydration. Heat-induced epitope retrieval was performed using citrate buffer (pH 6) in a pressure cooker. Tissue sections were incubated with 3% hydrogen peroxidase for 15 min to block endogenous peroxidase activity, followed by incubation with primary antibodies overnight in a humidified chamber at 4 °C. Immunostaining was visualized with a labeled streptavidin-biotin using 3,3′-diaminobenzidine as a chromogen and counterstained with hematoxylin. All the samples were first quantitatively analyzed and scored based on 2 independent criteria. First, the intensity of staining was scored on a scale of 0 to 3, where 0 = no staining, 1 = light brown, 2 = brown, and 3 = dark brown. Second, the percentage of the cells that stained positive in the tumor area was scored on a scale of 0 to 4, where 0 = 0, 1 = ≤10%, 2 = 11–50%, 3 = 51–75%, and 4 = >75%. Subsequently, each tumor sample was assigned a final score, which is the product of its (intensity of staining) × (% cells that stained positive). Tumors were categorized as negative when their final score was <3 and as positive when their final score was ≥3.

Statistical analyses

Statistical evaluation was performed using GraphPad Prism 5 software. Unless stated otherwise, statistical significance was determined using Student’s t test. The associations between the expression level of Daple isoforms and K-ras mutation status and metastatic status of disease were investigated by Fisher’s exact test. Parametric Pearson’s correlation and nonparametric Spearman’s correlation analysis were used to assess the relationship between the expression of Daple isoforms and patients’ age, tumor size, differentiation and grading, the level of Ki67-Index, Osteopontin, SASH1, MACC1 and CEA. In order to derive optimal cut-off values of gene expression levels, maximally selected log-rank statistics performed by Cutoff Finder (R Software version 2.15.0.)⁴⁹ were used. Time-dependent survival probabilities were estimated with the Kaplan-Meier method using the log-rank test. All statistical tests were performed two-sided, and p- values less than 0.05 were considered to be statistically significant.

References

Aznar, N. et al. Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling. Elife 4, e07091, https://doi.org/10.7554/eLife.07091 (2015).
Article CAS PubMed PubMed Central Google Scholar
Oshita, A. et al. Identification and characterization of a novel Dvl-binding protein that suppresses Wnt signalling pathway. Genes to cells: devoted to molecular & cellular mechanisms 8, 1005–1017 (2003).
Article CAS Google Scholar
Kobayashi, H. et al. Novel Daple-like protein positively regulates both the Wnt/beta-catenin pathway and the Wnt/JNK pathway in Xenopus. Mechanisms of development 122, 1138–1153, https://doi.org/10.1016/j.mod.2005.05.003 (2005).
Article CAS PubMed Google Scholar
Aznar, N. et al. Convergence of Wnt, growth factor, and heterotrimeric G protein signals on the guanine nucleotide exchange factor Daple. Sci Signal 11, https://doi.org/10.1126/scisignal.aao4220 (2018).
Article PubMed PubMed Central Google Scholar
Ishida-Takagishi, M. et al. The Dishevelled-associating protein Daple controls the non-canonical Wnt/Rac pathway and cell motility. Nature communications 3, 859, https://doi.org/10.1038/ncomms1861 (2012).
Article ADS CAS PubMed Google Scholar
Niavarani, A. et al. A 4-gene expression score associated with high levels of Wilms Tumor-1 (WT1) expression is an adverse prognostic factor in acute myeloid leukaemia. British journal of haematology 172, 401–411, https://doi.org/10.1111/bjh.13836 (2016).
Article CAS PubMed Google Scholar
Barbazan, J. et al. Prognostic Impact of Modulators of G proteins in Circulating Tumor Cells from Patients with Metastatic Colorectal Cancer. Sci Rep 6, 22112, https://doi.org/10.1038/srep22112 (2016).
Article ADS CAS PubMed PubMed Central Google Scholar
Larochelle, S. SYSTEMS BIOLOGY. Protein isoforms: more than meets the eye. Nat Methods 13, 291 (2016).
Article PubMed Google Scholar
Kozak, M. Point mutations close to the AUG initiator codon affect the efficiency of translation of rat preproinsulin in vivo. Nature 308, 241–246 (1984).
Article ADS CAS PubMed Google Scholar
Kozak, M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44, 283–292 (1986).
Article CAS PubMed Google Scholar
Aznar, N. et al. A Daple-Akt feed-forward loop enhances noncanonical Wnt signals by compartmentalizing beta-catenin. Mol Biol Cell 28, 3709–3723, https://doi.org/10.1091/mbc.E17-06-0405 (2017).
Article CAS PubMed PubMed Central Google Scholar
Takagishi, M. et al. Daple Coordinates Planar Polarized Microtubule Dynamics in Ependymal Cells and Contributes to Hydrocephalus. Cell Rep 20, 960–972, https://doi.org/10.1016/j.celrep.2017.06.089 (2017).
Article CAS PubMed Google Scholar
Wunsch, H. COX provides missing link in mechanism of aspirin in colon cancer. Lancet 351, 1864, https://doi.org/10.1016/S0140-6736(05)78812-7 (1998).
Article CAS PubMed Google Scholar
Thun, M. J., Namboodiri, M. M. & Heath, C. W. Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325, 1593–1596, https://doi.org/10.1056/NEJM199112053252301 (1991).
Article CAS PubMed Google Scholar
Zumwalt, T. J. et al. Aspirin-Induced Chemoprevention and Response Kinetics Are Enhanced by PIK3CA Mutations in Colorectal Cancer Cells. Cancer Prev Res (Phila) 10, 208–218, https://doi.org/10.1158/1940-6207.CAPR-16-0175 (2017).
Article CAS Google Scholar
Goel, A., Chang, D. K., Ricciardiello, L., Gasche, C. & Boland, C. R. A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells. Clin Cancer Res 9, 383–390 (2003).
CAS PubMed Google Scholar
Johnson, C. C. et al. Non-steroidal anti-inflammatory drug use and colorectal polyps in the Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial. Am J Gastroenterol 105, 2646–2655, https://doi.org/10.1038/ajg.2010.349 (2010).
Article CAS PubMed PubMed Central Google Scholar
Barry, E. L. et al. Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence–data from a randomized clinical trial. Cancer Epidemiol Biomarkers Prev 18, 2726–2733, https://doi.org/10.1158/1055-9965.EPI-09-0363 (2009).
Article CAS PubMed PubMed Central Google Scholar
Elwood, P. C. et al. Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies. PLoS One 11, e0152402, https://doi.org/10.1371/journal.pone.0152402 (2016).
Article CAS PubMed PubMed Central Google Scholar
Guillem-Llobat, P. et al. Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells. Oncotarget 7, 32462–32477, https://doi.org/10.18632/oncotarget.8655 (2016).
Article PubMed PubMed Central Google Scholar
Jones, M. K. et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 5, 1418–1423, https://doi.org/10.1038/70995 (1999).
Article CAS PubMed Google Scholar
Ellis, M. J. et al. Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance). J Clin Oncol 35, 1061–1069, https://doi.org/10.1200/JCO.2016.69.4406 (2017).
Article CAS PubMed PubMed Central Google Scholar
Niikura, N. et al. Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancer. Cancer Sci 103, 1508–1512, https://doi.org/10.1111/j.1349-7006.2012.02319.x (2012).
Article CAS PubMed PubMed Central Google Scholar
Martini, M., Gnann, A., Scheikl, D., Holzmann, B. & Janssen, K. P. The candidate tumor suppressor SASH1 interacts with the actin cytoskeleton and stimulates cell-matrix adhesion. Int J Biochem Cell Biol 43, 1630–1640, https://doi.org/10.1016/j.biocel.2011.07.012 (2011).
Article CAS PubMed Google Scholar
Zeller, C. et al. SASH1: a candidate tumor suppressor gene on chromosome 6q24.3 is downregulated in breast cancer. Oncogene 22, 2972–2983, https://doi.org/10.1038/sj.onc.1206474 (2003).
Article CAS PubMed Google Scholar
Redwine, W. B. et al. The human cytoplasmic dynein interactome reveals novel activators of motility. Elife 6, https://doi.org/10.7554/eLife.28257 (2017).
Liao, X. et al. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med 367, 1596–1606, https://doi.org/10.1056/NEJMoa1207756 (2012).
Article CAS PubMed PubMed Central Google Scholar
Ogino, S. et al. Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology. Oncogene 33, 2949–2955, https://doi.org/10.1038/onc.2013.244 (2014).
Article CAS PubMed Google Scholar
Gu, M. et al. Aspirin exerts high anti-cancer activity in PIK3CA-mutant colon cancer cells. Oncotarget 8, 87379–87389, https://doi.org/10.18632/oncotarget.20972 (2017).
Article PubMed PubMed Central Google Scholar
Dunkel, Y. et al. Prognostic Relevance of CCDC88C (Daple) Transcripts in the Peripheral Blood of Patients with Cutaneous Melanoma. Sci Rep 8, 18036, https://doi.org/10.1038/s41598-018-36173-x (2018).
Article ADS CAS PubMed PubMed Central Google Scholar
Ghosh, P., Garcia-Marcos, M., Bornheimer, S. J. & Farquhar, M. G. Activation of Galphai3 triggers cell migration via regulation of GIV. J Cell Biol 182, 381–393, https://doi.org/10.1083/jcb.200712066 (2008).
Article PubMed PubMed Central Google Scholar
Ghosh, P. et al. A G{alpha}i-GIV molecular complex binds epidermal growth factor receptor and determines whether cells migrate or proliferate. Mol Biol Cell 21, 2338–2354, https://doi.org/10.1091/mbc.E10-01-0028 (2010).
Article CAS PubMed PubMed Central Google Scholar
Garcia-Marcos, M., Ghosh, P. & Farquhar, M. G. GIV is a nonreceptor GEF for G alpha i with a unique motif that regulates Akt signaling. Proc Natl Acad Sci USA 106, 3178–3183, https://doi.org/10.1073/pnas.0900294106 (2009).
Article ADS PubMed PubMed Central Google Scholar
Garcia-Marcos, M., Ghosh, P., Ear, J. & Farquhar, M. G. A structural determinant that renders G alpha(i) sensitive to activation by GIV/girdin is required to promote cell migration. J Biol Chem 285, 12765–12777, https://doi.org/10.1074/jbc.M109.045161 (2010).
Article CAS PubMed PubMed Central Google Scholar
Garcia-Marcos, M., Kietrsunthorn, P. S., Wang, H., Ghosh, P. & Farquhar, M. G. G Protein binding sites on Calnuc (nucleobindin 1) and NUCB2 (nucleobindin 2) define a new class of G(alpha)i-regulatory motifs. J Biol Chem 286, 28138–28149, https://doi.org/10.1074/jbc.M110.204099 (2011).
Article CAS PubMed PubMed Central Google Scholar
Yao, R., Natsume, Y. & Noda, T. MAGI-3 is involved in the regulation of the JNK signaling pathway as a scaffold protein for frizzled and Ltap. Oncogene 23, 6023–6030, https://doi.org/10.1038/sj.onc.1207817 (2004).
Article CAS PubMed Google Scholar
Garcia-Marcos, M., Ear, J., Farquhar, M. G. & Ghosh, P. A GDI (AGS3) and a GEF (GIV) regulate autophagy by balancing G protein activity and growth factor signals. Mol Biol Cell 22, 673–686, https://doi.org/10.1091/mbc.E10-08-0738 (2011).
Article CAS PubMed PubMed Central Google Scholar
Voloshanenko, O. et al. Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells. Nature communications 4, 2610, https://doi.org/10.1038/ncomms3610 (2013).
Article ADS CAS PubMed Google Scholar
Bondy, G. P., Wilson, S. & Chambers, A. F. Experimental metastatic ability of H-ras-transformed NIH3T3 cells. Cancer research 45, 6005–6009 (1985).
CAS PubMed Google Scholar
Hill, S. A., Wilson, S. & Chambers, A. F. Clonal heterogeneity, experimental metastatic ability, and p21 expression in H-ras-transformed NIH 3T3 cells. Journal of the National Cancer Institute 80, 484–490 (1988).
Article CAS PubMed Google Scholar
Chambers, A. F., Denhardt, G. H. & Wilson, S. M. ras-transformed NIH 3T3 cell lines, selected for metastatic ability in chick embryos, have increased proportions of p21-expressing cells and are metastatic in nude mice. Invasion & metastasis 10, 225–240 (1990).
CAS Google Scholar
Tuck, A. B., Wilson, S. M., Khokha, R. & Chambers, A. F. Different patterns of gene expression in ras-resistant and ras-sensitive cells. Journal of the National Cancer Institute 83, 485–491 (1991).
Article CAS PubMed Google Scholar
Leitner, L. et al. MAL/MRTF-A controls migration of non-invasive cells by upregulation of cytoskeleton-associated proteins. Journal of cell science 124, 4318–4331, https://doi.org/10.1242/jcs.092791 (2011).
Article CAS PubMed Google Scholar
Garcia-Marcos, M. et al. Functional characterization of the guanine nucleotide exchange factor (GEF) motif of GIV protein reveals a threshold effect in signaling. Proc Natl Acad Sci USA 109, 1961–1966, https://doi.org/10.1073/pnas.1120538109 (2012).
Article ADS PubMed PubMed Central Google Scholar
Yang, I. S., Son, H., Kim, S. & Kim, S. ISOexpresso: a web-based platform for isoform-level expression analysis in human cancer. BMC Genomics 17, 631, https://doi.org/10.1186/s12864-016-2852-6 (2016).
Article PubMed PubMed Central Google Scholar
Lin, C. et al. Tyrosine phosphorylation of the Galpha-interacting protein GIV promotes activation of phosphoinositide 3-kinase during cell migration. Sci Signal 4, ra64, https://doi.org/10.1126/scisignal.2002049 (2011).
Article CAS PubMed PubMed Central Google Scholar
Fuerer, C. & Nusse, R. Lentiviral vectors to probe and manipulate the Wnt signaling pathway. PLoS One 5, e9370, https://doi.org/10.1371/journal.pone.0009370 (2010).
Article ADS CAS PubMed PubMed Central Google Scholar
Nitsche, U. et al. Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer. Annals of surgery 256(763–771), discussion 771, https://doi.org/10.1097/SLA.0b013e318272de87 (2012).
Article Google Scholar
Budczies, J. et al. Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. PLoS One 7, e51862, https://doi.org/10.1371/journal.pone.0051862 (2012).
Article ADS CAS PubMed PubMed Central Google Scholar
Ahmed, D. et al. Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis 2, e71, https://doi.org/10.1038/oncsis.2013.35 (2013).
Article CAS PubMed PubMed Central Google Scholar

Download references

Acknowledgements

This work was supported by NIH grants CA100768, CA160911 and DK099226 (to P.G.). P.G. was also supported by the American Cancer Society (ACS-IRG 70-002) and by the UC San Diego Moores Cancer Center. J.E. was supported by a NCI/NIH-funded Cancer Biology, Informatics & Omics (CBIO) Training Program (T32 CA067754) and a Postdoctoral Fellowship, PF-18-101-01-CSM, from the American Cancer Society, Y.M. was supported by the NIH Training Grant in Gastroenterology (T32DK0070202) and a Clinical and Translational Science Awards (CTSA) Program (TL1TR001443), and J.B. by a fellowship from the Spanish Ministry of Education, Culture and Sports (FPU, AP2009-5229). Other sources of funding include NIH R01CA72851 (to A.G.), the German ministry of education and research (BMBF/m4 Biobank Alliance) and funds from the KommissionfürklinischeForschung(to U.N. and K.P.-J.).

Author information

Jason Ear, Ying Dunkel and Nicolas Aznar contributed equally.

Authors and Affiliations

Department of Medicine, University of California, San Diego, La Jolla, California, USA
Jason Ear, Ying Dunkel, Yash Mittal, Blaze B. C. Lim, Lawrence Liu, Magda K. Holda, Nicolas Aznar & Pradipta Ghosh
Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California, USA
Jason Ear & Pradipta Ghosh
Department of Surgery, Klinikumrechts der Isar, TechnischeUniversitätMünchen, Munich, Germany
Ulrich Nitsche & Klaus-Peter Janssen
Translational Medical Oncology Laboratory, Health Research Institute of Santiago (IDIS), SERGAS., Santiago de Compostela, Spain
Jorge Barbazán
Division of Gastroenterology, Department of Internal Medicine and Charles A. Sammons Cancer Center and Baylor Research Institute, Baylor University Medical Center, Dallas, Texas, USA
Ajay Goel
Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France
Nicolas Aznar
Moores Cancer Center, University of California, San Diego, La Jolla, California, USA
Pradipta Ghosh

Authors

Jason Ear
View author publications
You can also search for this author in PubMed Google Scholar
Ying Dunkel
View author publications
You can also search for this author in PubMed Google Scholar
Yash Mittal
View author publications
You can also search for this author in PubMed Google Scholar
Blaze B. C. Lim
View author publications
You can also search for this author in PubMed Google Scholar
Lawrence Liu
View author publications
You can also search for this author in PubMed Google Scholar
Magda K. Holda
View author publications
You can also search for this author in PubMed Google Scholar
Ulrich Nitsche
View author publications
You can also search for this author in PubMed Google Scholar
Jorge Barbazán
View author publications
You can also search for this author in PubMed Google Scholar
Ajay Goel
View author publications
You can also search for this author in PubMed Google Scholar
Klaus-Peter Janssen
View author publications
You can also search for this author in PubMed Google Scholar
Nicolas Aznar
View author publications
You can also search for this author in PubMed Google Scholar
Pradipta Ghosh
View author publications
You can also search for this author in PubMed Google Scholar

Contributions

J.E., Y.D., N.A. and P.G. designed, performed and analyzed most of the experiments in this work. N.A. and Y.D. carried out the biochemical and cell biological characterization studies comparing the two Daple isoforms. Y.D., L.L. and J.E. carried out most of the molecular biology experiments and identification of isoforms. Y.D., Y.M. B.B.C.L., M.K.H. and P.G. carried out the IHC studies on FFPE patient tissues. U.N. and K.-P.J. provided access to CRC Stage-II cohort and primary tumor-derived RNA and U.N. and Y.D. generated and analyzed the data. J.B. and Y.D. carried out the analyses of Daple in CTCs. A.G. provided access to adenomas, and contributed unpublished essential data or reagents. Y.D., N.A. and P.G. conceived the project and wrote the manuscript. P.G. supervised and funded the project.

Corresponding authors

Correspondence to Nicolas Aznar or Pradipta Ghosh.

Ethics declarations

Competing Interests

The authors declare no competing interests.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Figures and Legends

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Cite this article

Ear, J., Dunkel, Y., Mittal, Y. et al. Two Isoforms of the Guanine Nucleotide Exchange Factor, Daple/CCDC88C Cooperate as Tumor Suppressors. Sci Rep 9, 12124 (2019). https://doi.org/10.1038/s41598-019-48420-w

Download citation

Received: 05 November 2018
Accepted: 01 August 2019
Published: 20 August 2019
DOI: https://doi.org/10.1038/s41598-019-48420-w

This article is cited by

CCDC88B interacts with RASAL3 and ARHGEF2 and regulates dendritic cell function in neuroinflammation and colitis
- Jean-Frederic Olivier
- David Langlais
- Nassima Fodil
Communications Biology (2024)

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.